You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SPECT-MIBI

Showing 1 - 25 of 558
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Hyperparathyroidism Trial in Odense C (Contrast-enhanced ultrasound)

Completed
  • Primary Hyperparathyroidism
  • Contrast-enhanced ultrasound
  • Odense C, Denmark
    Odense University Hospital
Apr 7, 2022

F-18 PSMA for Localization of Parathyroid Adenoma

Recruiting
  • Hyperparathyroidism
  • 99mTc-MIBI planar imaging and SPECT/CT.
  • F- 18PSMA PET/CT imaging study
  • Atlanta, Georgia
  • +2 more
Mar 31, 2022

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting
  • 18F-fluorocholine
  • +2 more
  • [F-18]-FCH PET/MRI
  • Toronto, Ont, Canada
    UHN
Dec 9, 2022

Correlation Between SPECT/CT and IDH Mutation in Brain Glioma

Not yet recruiting
  • Brain Glioma
    • (no location specified)
    Oct 23, 2022

    Peripheral Artery Disease Trial in Beijing (NL003, Placebo)

    Recruiting
    • Peripheral Artery Disease
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 20, 2023

    Primary Hyperparathyroidism, Thyroid Disease, Parathyroid Diseases Trial in Ostrava (Conventional (dual-phase) SPECT/CT,

    Completed
    • Primary Hyperparathyroidism
    • +3 more
    • Conventional (dual-phase) SPECT/CT
    • +3 more
    • Ostrava, Moravian-Silesian Region, Czechia
      University Hospital Ostrava
    Dec 6, 2022

    Single Photon Emission Computed Tomography/Computed Tomography

    Not yet recruiting
    • Brain Glioma
    • SPECT with pentavalent 99mTc DMSA
    • (no location specified)
    Oct 23, 2022

    Viable Myocardium Detected by Hybrid PET/MR and SPECT for

    Recruiting
    • Chronic Total Occlusion of Coronary Artery
    • CTO PCI
    • Nanjing, Jiangsu, China
      First Affiliated Hospital of Nanjing Medical University
    Oct 30, 2023

    SPECT Myocardial Blood Flow Quantitation for Detection of

    Completed
    • Coronary Artery Disease
      • Beijing, China
      • +3 more
      Jan 19, 2022

      Mitochondria in Cardiomyocytes in Heart Failure

      Not yet recruiting
      • Heart Failure
      • Coronary Artery Disease
      • coronary artery bypass grafting
      • (no location specified)
      Mar 3, 2023

      Osteoarthritis Ankle, Osteoarthritis Trial in Groningen (SPECT/CT, MRI)

      Not yet recruiting
      • Osteoarthritis Ankle
      • Osteoarthritis
      • SPECT/CT
      • MRI
      • Groningen, Netherlands
        Martini Hospital
      Jun 12, 2023

      Contractile and Coronary Reserve in Ischemic Cardiomyopathy

      Completed
      • Ischemic Cardiomyopathy
      • Stress Gated blood pool SPECT
      • Dynamic SPECT
      • Tomsk, Russian Federation
        Cardiology Research Institute, Tomsk National Research Medical C
      Oct 5, 2021

      Malignant Tumor Trial in Beijing (99mTc-CNDG SPECT/CT)

      Recruiting
      • Malignant Tumor
      • 99mTc-CNDG SPECT/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Sep 3, 2023

      Diagnosis of Ischemic Heart Disease Determined by Fraction Flow

      Recruiting
      • Coronary Artery Disease
        • Beijing, Beijing, China
          Fuwai Hospital
        Sep 7, 2023

        Myocardial Infarction Trial in Nantes (Dynamic 99mTc-Tetrofosmin CZT-SPECT)

        Not yet recruiting
        • Myocardial Infarction
        • Dynamic 99mTc-Tetrofosmin CZT-SPECT
        • Nantes, France
          Nantes University Hospital
        Jul 3, 2023

        NSCLC Trial (99mTc-H7ND SPECT/CT imaging performed)

        Not yet recruiting
        • NSCLC
        • 99mTc-H7ND SPECT/CT imaging performed
        • (no location specified)
        Aug 17, 2023

        99mTc-DARPinG3 SPECT/CT for Non-invasive HER2-AX in Breast

        Enrolling by invitation
        • Breast Cancer Female
        • 99mTc-DARPinG3 SPECT/CT
        • Tomsk, Russian Federation
          Russia Tomsk NRMC
        Jan 23, 2023

        Prostate Cancer Trial in Wuxi (177Lu-labeled NY108)

        Recruiting
        • Prostate Cancer
        • 177Lu-labeled NY108
        • Wuxi, Jiangsu, China
          Affiliated Hospital of Jiangnan University
        Apr 4, 2023

        Pulmonary Fibrosis Trial in Beijing (99mTc-HFAPI)

        Recruiting
        • Pulmonary Fibrosis
        • Beijing, Dongcheng, China
          Peking union medical college hospital
        May 5, 2023

        Breast Cancer Trial in Beijing (99mTc-MIRC213)

        Recruiting
        • Breast Cancer
        • Beijing, China
          Peking Union Medical College Hospital, Chinese Academy of Medica
        Nov 18, 2022

        Parathyroid Adenoma, Hyperparathyroidism, F18-choline Trial in Brest, Caen, Rennes (MIBI scintigraphy, F18-choline PET)

        Active, not recruiting
        • Parathyroid Adenoma
        • +2 more
        • MIBI scintigraphy
        • F18-choline PET
        • Brest, France
        • +3 more
        May 6, 2022

        Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Recurrent Head and Neck Squamous Cell Carcinoma
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Jul 13, 2023

        Cancer Trial in Beijing (99mTc-MIRC208)

        Recruiting
        • Cancer
        • Beijing, Beijing, China
          Hua Zhu
        Jul 18, 2022

        123 I-FP-CIT SPECT Prescriptions for Parkinsonian Syndromes

        Completed
        • Parkinson
          • Bobigny, France
            Hôpital Avicenne
          Jan 16, 2023

          Coronary Artery Disease Trial in Oklahoma City (99mTc-Sestamibi)

          Active, not recruiting
          • Coronary Artery Disease
          • 99mTc-Sestamibi
          • Oklahoma City, Oklahoma
            Tom Hennebry, MD
          Jan 28, 2021